FDA wants suggestions to guide its Nicotine Steering Committee headed by Commissioner Scott Gottlieb for the agency's evaluation for modernizing its approach on developing and regulating nicotine replacement therapies.
In a Federal Register notice, FDA announced a docket, FDA-2018-N-0128, that will be open for comments through April 16....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?